Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology Inc (NQ: NAUT )

2.770 +0.140 (+5.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 166,009
Open 2.630
Bid (Size) 2.770 (4)
Ask (Size) 2.890 (3)
Prev. Close 2.630
Today's Range 2.630 - 2.830
52wk Range 1.500 - 5.065
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology Announces “First Access Challenge” Winners
Researchers from Buck Institute for Research on Aging, Brigham Young University and University of Southern California awarded early access to Nautilus’ single-molecule protein analysis platform 
From Nautilus Biotechnology Inc.
Via Globe NewsWire

Performance

YTD
+63.91%
+63.91%
1 Month
+28.84%
+28.84%
3 Month
+53.89%
+53.89%
6 Month
+30.66%
+30.66%
1 Year
-36.18%
-36.18%

More News

Read More
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Recap: Nautilus Biotechnology Q3 Earnings
Via Benzinga
Recap: Nautilus Biotechnology Q2 Earnings
Via Benzinga
Earnings Scheduled For February 23, 2023
Via Benzinga
Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology Expands to San Diego
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Nautilus Biotechnology Launches “First Access Challenge”
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
From Nautilus Biotechnology Inc.
Via Globe NewsWire
Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022
From Nautilus Biotechnology Inc.
Via Globe NewsWire
$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Earnings Scheduled For November 1, 2022
Via Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Via Benzinga
$1.2 Million Bet On Gannett? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Via Benzinga
A Preview Of Nautilus Biotechnology's Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Earnings Scheduled For August 2, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.